• Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Calithera Biosciences Inc

+ Add to Watchlist


16.989 EUR 2.598 13.26%

As of 15:17:41 ET on 12/23/2014.

Snapshot for Calithera Biosciences Inc (2CB)

Open: 18.305 Day's Range: 16.989 - 18.700 Volume: 543
Previous Close: 19.587 52wk Range: 3.525 - 26.000 1-Yr Rtn: -

Stock Chart for 2CB

No chart data available.
  • 2CB:GR 17.236
  • 1D
  • 1M
  • 1Y
Interactive 2CB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 2CB

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -1.8570
Est. PEG Ratio -
Market Cap (M EUR) 14,621.73
Shares Outstanding (M) 860.66
30 Day Average Volume 94
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 2CB

No data available

Company Profile & Key Executives for 2CB

Calithera Biosciences, Inc. provides pharmaceutical products. The Company is focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer. Calithera Biosciences serves customers in the United States.

Ralph E Christoffersen "Chris"ChairmanSusan M MolineauxPresident/CEO/Co-Founder
William D WaddillSenior VP/CFO/Treasurer/SecyEric B SjogrenSenior VP:Drug Discovery
More Company Profile & Key Executives for 2CB

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil